HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinomaMasahiro Shitani, Yasutoshi Kimura, Hiroshi Kawakami et al.|Scientific Reports|2022Cited by 3